ArticleBMC ophthalmology2025
Clinical characteristics and outcomes of acute retinal necrosis at different stages: a retrospective study.
Article in BMC ophthalmology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Predictors of retinal detachment and visual outcome in acute retinal necrosis: a 14-year retrospective cohort.Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2026Article
- Outcomes of Patients with Acute Retinal Necrosis (ARN) presenting to a Canadian tertiary care centre: a 5-year retrospective cohort study.Journal of ophthalmic inflammation and infection · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
backgroundTo examine the clinical features and treatment outcomes of patients with acute retinal necrosis (ARN) at different disease stages and identify the risk factors associated with a poor prognosis.
methodsThis retrospective study included 39 patients (44 eyes) with ARN who were treated at a single center. The eyes were divided into three stages based on the ocular findings and clinical course at the initial diagnosis. The main outcome measures were the incidence of retinal detachment (RD) and final visual acuity (VA). Regression analyses were performed to investigate the risk factors associated with the main outcomes.
resultsNine, 10, and 25 eyes were in the early, middle, and late stages, respectively. Eyes in the early stage had the shortest symptom duration (P = 0.019). At the first visit, the intraocular pressure (IOP) was elevated in half the patients; 29 eyes (65.9%) had keratic precipitates (KPs) and five (11.6%) had iris nodules. The final VA improved in early-stage eyes (P = 0.008) and decreased in late-stage eyes (P = 0.004) after treatment. RD was not common with early diagnosis. Five (50%) and 17 (68%) eyes in the middle and late stages developed RD, respectively. Independent predictors of RD included the vitritis grade (P = 0.046) and clock hours of retinitis (P = 0.045). Initial VA at presentation (β = 0.291, P = 0.009), the occurrence of RD (β = 0.209, P = 0.033), and clock hours of retinitis (β = 0.323, P = 0.008) were identified as associated with final VA.
conclusionEarly diagnosis and treatment are associated with positive clinical outcomes. Anterior segment signs (e.g., mildly or moderately elevated IOP, KPs, and iris nodules) are important for early diagnosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.